This article is part of a series featuring Utah-based companies and what they’re doing during the coronavirus pandemic.

The approval of Spectrum Solutions saliva collection device gives patients an alternative to the intrusive swab collection typically used to test for COVID-19.

The company recently announced it obtained approval from the Food and Drug Administration (FDA) for Emergency Use Authorization for its Spectrum SDNA-1000 saliva collection device.

Patients take the top off the testing device and spit into it. “You take the top of the device, and you turn it, then it punctures the saliva into the tube,” said Stephen Fanning, CEO of Spectrum Solutions. “Our proprietary preservative kills the coronavirus, but it leaves behind what are called the ribonucleic acid, or RNA markers. By killing the virus, there’s not the issue that they can potentially become infected as a result of opening that up. More importantly, the preservative maintains the RNA markers to determine if you, in fact, have the virus.”

The study was conducted last month and immediately submitted to the FDA. For now, the saliva testing method is being used by individual health care providers under an emergency use authorization from the FDA. Each health care provider must apply for their own authorization.

“Using saliva to test for COVID-19 overcomes many of the challenges the nation faces that are inherent to current testing methods including supply shortages and risks to exposure for healthcare professionals,” said Fanning.

Spectrum plans to hire additional staff and increase the capacity of its Utah manufacturing facility to more than triple production of the SDNA-1000.